Department of Surgery, Ersta Hospital, Stockholm, Sweden.
Dis Colon Rectum. 2011 Jun;54(6):672-80. doi: 10.1007/DCR.0b013e318210c067.
Preoperative irradiation with 5 × 5 Gy in randomized trials reduces local recurrence rate and may improve survival in patients with resectable rectal cancer.
The aim of this study was to determine whether the same favorable effects could be observed in a population-based study.
This study was conducted via a retrospective analysis of prospectively collected data from the Swedish Rectal Cancer Registry.
This study examined population-based data from Sweden.
All newly diagnosed rectal cancers in Sweden are reported to the Swedish Rectal Cancer Registry.
Between 1995 and 2001, 6878 patients (stages I-III) were operated on with an anterior resection, an abdominoperineal resection, or a Hartmann's procedure. Short-course irradiation was given to 41% of patients preoperatively. To reduce bias, patients operated on with a Hartmann procedure or older than 75 years were excluded when 5-year survival was analyzed (n = 3466). Tumors were analyzed according to height (0-5 cm, 6-10 cm, 11-15 cm).
Five-year cumulative local recurrence and survival rates.
The 5-year cumulative local recurrence rate was 6.3% (95% CI 5.4-7.4) for patients receiving preoperative irradiation and 12.1% (95% CI 10.8-13.5) for patients not receiving preoperative irradiation. Multivariate analyses indicated the risk of local recurrence was 50% lower for patients receiving preoperative irradiation compared with patients not receiving irradiation (hazard ratio = 0.50; 95% CI 0.40-0.62). Among patients younger than 76 years and operated on with an anterior resection or abdominoperineal resection, the 5-year cumulative survival rate was 0.70 (95% CI 0.69-0.72). Disease-free and overall survivals were higher in irradiated patients, and the difference was statistically significant in low tumors.
In this population-based analysis, the favorable effect of preoperative short-course irradiation on local recurrence rates, seen in randomized trials, was confirmed for the entire Swedish population irrespective of tumor height and stage. Data also suggested an effect on 5-year survival, especially in patients with low tumors (0-5 cm).
在随机试验中,术前给予 5×5 Gy 的照射可降低局部复发率,并可能改善可切除直肠癌患者的生存率。
本研究旨在确定这种有利影响是否可以在基于人群的研究中观察到。
本研究通过对瑞典直肠肿瘤登记处前瞻性收集的数据进行回顾性分析进行。
本研究检查了来自瑞典的基于人群的数据。
所有新诊断的直肠癌患者均向瑞典直肠肿瘤登记处报告。
1995 年至 2001 年间,对 6878 例患者(I-III 期)进行了前切除术、腹会阴切除术或 Hartmann 手术。41%的患者术前接受了短程照射。为了减少偏倚,当分析 5 年生存率时,排除了接受 Hartmann 手术或年龄大于 75 岁的患者(n=3466)。根据肿瘤高度(0-5cm、6-10cm、11-15cm)分析肿瘤。
5 年累积局部复发率和生存率。
接受术前照射的患者 5 年累积局部复发率为 6.3%(95%CI5.4-7.4),未接受术前照射的患者为 12.1%(95%CI10.8-13.5)。多变量分析表明,与未接受照射的患者相比,接受术前照射的患者局部复发的风险降低了 50%(风险比=0.50;95%CI0.40-0.62)。在年龄小于 76 岁且接受前切除术或腹会阴切除术的患者中,5 年累积生存率为 0.70(95%CI0.69-0.72)。照射组的疾病无进展和总生存率较高,且在低肿瘤患者中差异具有统计学意义。
在这项基于人群的分析中,术前短程照射对局部复发率的有利影响在随机试验中得到了证实,适用于整个瑞典人群,与肿瘤高度和分期无关。数据还表明,5 年生存率也有影响,尤其是在低肿瘤(0-5cm)患者中。